Oza AM - Search Results

1

Oza AM, Rohatiner AZ, Lister TA. Oza AM, et al. Baillieres Clin Haematol. 1991 Jan;4(1):131-56. doi: 10.1016/s0950-3536(05)80288-4. Baillieres Clin Haematol. 1991. PMID: 2039855 Review.

2

Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.

Ganesan TS, Oza A, Perry N, D'Ardenne J, Arnott S, Stansfeld AG, Shand WS, Wrigley PF, Lister TA. Ganesan TS, et al. Ann Oncol. 1992 May;3(5):349-56. doi: 10.1093/oxfordjournals.annonc.a058204. Ann Oncol. 1992. PMID: 1377487 Free article.

3

Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.

Radford JA, Crowther D, Rohatiner AZ, Ryder WD, Gupta RK, Oza A, Deakin DP, Arnott S, Wilkinson PM, James RD, et al. Radford JA, et al. J Clin Oncol. 1995 Sep;13(9):2379-85. doi: 10.1200/JCO.1995.13.9.2379. J Clin Oncol. 1995. PMID: 7666097 Clinical Trial.

4

Intensive chemotherapy for acute lymphoblastic leukaemia in adults.

Rohatiner AZ, Bassan R, Battista R, Barnett MJ, Gregory W, Lim J, Amess J, Oza A, Barbui T, Horton M, et al. Rohatiner AZ, et al. Haematol Blood Transfus. 1990;33:413-8. doi: 10.1007/978-3-642-74643-7_77. Haematol Blood Transfus. 1990. PMID: 2182432 Clinical Trial. No abstract available.

5

Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in Hodgkin's disease.

Oza AM, Leahy M, Dorey E, Davis CL, Amess J, Horton M, Rohatiner AZ, Wrigley PF, Lister TA. Oza AM, et al. Hematol Oncol. 1991 Nov-Dec;9(6):337-47. doi: 10.1002/hon.2900090608. Hematol Oncol. 1991. PMID: 1748400

6

The treatment of stage IIIA Hodgkin's disease--total nodal irradiation versus combination chemotherapy: either or neither.

Oza AM, Leahy M, Lim J, Gregory W, Stansfeld AG, Wrigley PF, Lister TA. Oza AM, et al. J Clin Oncol. 1991 Aug;9(8):1514-6. doi: 10.1200/JCO.1991.9.8.1514. J Clin Oncol. 1991. PMID: 2072154 Clinical Trial. No abstract available.

7

Diagnosis and staging of Hodgkin's disease.

Oza AM, Lister TA. Oza AM, et al. Curr Opin Oncol. 1990 Oct;2(5):832-7. doi: 10.1097/00001622-199010000-00005. Curr Opin Oncol. 1990. PMID: 2095887 Review. No abstract available.

8

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.

Rohatiner AZ, Bassan R, Battista R, Barnett MJ, Gregory W, Lim J, Amess J, Oza A, Barbui T, Horton M, et al. Rohatiner AZ, et al. Br J Cancer. 1990 Sep;62(3):454-8. doi: 10.1038/bjc.1990.317. Br J Cancer. 1990. PMID: 2206954 Free PMC article.

9

Association of HLA-DPB with Hodgkin's disease.

Tonks S, Oza AM, Lister TA, Bodmer JG. Tonks S, et al. Among authors: oza am. Lancet. 1992 Oct 17;340(8825):968-9. doi: 10.1016/0140-6736(92)92850-f. Lancet. 1992. PMID: 1357360 No abstract available.

10

HLA-DP based resistance to Hodgkin's disease.

Bodmer JG, Tonks S, Oza AM, Lister TA, Bodmer WF. Bodmer JG, et al. Among authors: oza am. Lancet. 1989 Jun 24;1(8652):1455-6. doi: 10.1016/s0140-6736(89)90166-9. Lancet. 1989. PMID: 2567468 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters